Peripheral blood blasts from a patient with acute megakaryoblastic leukemia were placed into liquid cultures with recombinant growth factors. Growth, but not differentiation, was supported by interleukin-3 (IL-3) or granulocyte-macrophage colony-stimulating factor (GM-CSF) for the first 30 days of culture. Sustained growth occurred only with GM-CSF and gave rise to the cell line MB-02, which has been in continuous culture for over 1 year. The cell line retained the surface phenotype of the leukemic megakaryoblasts except for the loss of glycoproteins Ib and llb/llla, which were induced after exposure t o phorbol esters. The induction of erythropoiesis occurred when GM-CSF-deprived cells were cultured with erythropoietin (Epo). Well-defined morphologic stages of differentiation ranging from primitive erythroblasts t o nucleiextruding normoblasts were seen. Transforming growth factor-$ inhibited GM-CSF-and Epo-dependent growth, but not HE AVAILABILITY of recombinant human growth
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Recently, cell lines dependent on granulocyte-macrophage colony-stimulating factor (GM-CSF) and/or interleukin-3 (IL-3) for growth have been obtained from patients with erythroleukemia (M6) or megakaryocytic leukemia (M7). Cell lines M-07 and UT-7, which were derived from patients with M7 and have properties of megakaryoblasts, require either GM-CSF and/or 1L-3.'~~ The TF-1 cell line, which has erythroid potential, was established from M6 BM cells and responds to either GM-CSF or IL-3.4 Even though these cell lines are responsive to normal hematopoietic regulators, none has been able to terminally differentiate into mature megakaryocytes or erythrocytes. Therefore, their usefulness for studying differentiation is limited. We describe here the biologic properties of MB-02, a new human cell line derived from M7 PB leukemic blast cells. In a preliminary report, globin chain analysis showed that uninduced cells produced fetal hemoglobin (Hb F) and the addition of erythropoietin (Epo) caused de novo synthesis of P-globin chains with a 580 x 10y/L; white blood cell count (WBC) 16 .3 X 10y/L with 81% polys, 2% bands, 1% metamyelocytes, 10% lymphocytes, 5% monocytes, and 1% eosinophils. There was an elevated leukocyte alkaline phosphatase (LAP) of 249. The BM biopsy and aspiration showed increased fibrosis with mature and immature megakaryocytes. The carcinoma was treated with radiation therapy and the myeloproliferative disorder was not treated.
In 1986 the patient was admitted to Hahnemann University Hospital with weakness, mouth pain, and failure to thrive. The PB counts were Hb 8.5 g/dL; Hct 27.2%; platelets 32 X 10y/L; WBC 19.9 x 10y/L with 17% blasts that were positive for glycoprotein (GP) Ib and GP IIblIIIa. Histochemical staining was negative for myeloperoxidase, napthol AS-D chloroacetate esterase, napthol AS-D acetate esterase, and acid phosphatase. The karyotype of the BM was hypodiploid with a modal chromosome number of 44XY. All of the dividing cells belonged to an abnormal clone characterized by additions to the short arms of chromosomes 1 and 3, monosomy of chromosomes 4,5,14, and 19 with the addition of two ring chromosomes. The BM biopsy showed numerous megakaryocytes and nests of immature cells, which led to a diagnosis of acute megakaryoblastic leukemia (M7). 6 The patient refused therapy and died 2 weeks later. His PB WBCwas 51.5 x 10y/L with 51% blasts.
PB was obtained from the patient in 1986 during the final hospital admission. More than 80% of the cells recovered after Ficoll density centrifugation'were positive for the platelet GP Ib and GP IIbiIIIa and retained the blebbing morphology of the circulating blasts. The cells were cryopreserved in nutrient medium containing 10% HS and 10% dimethyl sulfoxide (DMSO).
In 1988, suspension cultures' were initiated by placing thawed leukemic cells into 16 x 125 mm tubes (Falcon, Oxnard, CA) at a final cell concentration of 1 x 106/2 mL of complete medium (RPMI 1640 containing 10% HS) and supplemented with Epo, IL-2, IL-3, TGF-$1, or GM-CSF. Growth factors were added as single doses as well as the following combinations: EPO + IL-2 + TGF. Control cell cultures received complete medium only. The cultures were kept at 37°C and 5% CO, in a humidified incubator. At designated intervals, cells were removed for viable cell counts by trypan blue exclusion and for morphologic examination of cytocentrifuge preparations using Wright-Giemsa staining.
Stock cultures were maintained by the continuous process of splitting the cultures to a lower cell density and refeeding with fresh complete medium containing GM-CSF. When GM-CSF depletion was required, cells were washed twice in nutrient medium and resuspended in complete medium containing the growth factor of choice. Cultured cells were cryopreserved at cell concentrations of 5 X 106/mLof complete medium containing 10% glycerol in place of DMSO.
For flow cytometry, cells were incubated with the primary antibodies for 1 hour at 4°C and washed once with phosphate-buffered saline (PBS) containing 1% bovine serum albumin (BSA) followed by incubation for 30 minutes at 4°C with a fluorescein-conjugated secondary antibody. Control cells were stained with the secondary antibody only. For fluorescent microscopy, cytocentrifuge preparations were fixed for 20 minutes in cold methanol, hydrated in PBS, and the primaxy antibody allowed to incubate at 37°C for 1 hour. After two washes with PBS, fluoroescein-conjugated secondary antibody was added for 45 minutes at 37°C. After another PBS wash, the cells were examined with a Zeiss fluorescence microscope. Cells cultured in GM-CSF were seeded into a culture flask at a density of 1 X 106/mL in 20 mL of complete medium containing GM-CSF and lo-' mol/L TPA. The control flask received GM-CSF only. Both
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Modulation of growth and differentiation by phorbol ester.
flasks were incubated at 37°C for 48 hours before culture termination by harvesting cells for membrane analysis by flow cytometry.
Cells were deprived of GM-CSF and seeded into 24-well culture plates (Nunc, Naperville, IL) at a final cell density of 1 X lO"l.5 mL of complete medium containing 4 U/mL of Epo either alone or in combination with GM-CSF. At selected intervals, viable cell counts were determined by trypan blue exclusion, differentiation was assessed by morphology, and the presence of Hb was determined by benzidine staining and globin chain expression by indirect immunofluorescence using globin chain-specific MoAbs.
TGF-$ was added directly to cultures containing either GM-CSF or Epo.
To provide a more receptive biologic surface for the cells, round-bottom microwells were coated with 0.2 mL of one of the following reactives: fibronectin (Sigma F2006; 1 mg/mL water), poly-lysine (Collaborative Research 350K, Bedford, MA, 1 mg/mL water), inactivated filtered fetal bovine serum, or collagen (Vitrogen 100 Collaborative Research). After remaining overnight at 4"C, the wells were rinsed with PBS. Alternatively, fibroblasts from human amnion cultures or normal human mononunlear cells were irradiated for 3 minutes at 4,500 rads and used as a feeder layer. Specifically, the mononuclear cells were allowed to adhere to plastic for 48 hours, and the nonadherent cells were then irradiated and seeded into each microwell at a concentration of 1 x l@/0.2 mL complete medium containing GM-CSF. After 48 hours, the microwells were ready to receive the MB-02 cell(s). Cells were diluted to contain from 1 to 100 cells/vol of complete medium containing GM-CSF and were added to a microwell containing complete medium and/or MB-02-conditioned medium that had been harvested 2 to 3 days after a culture split and passed through a 0.45-p syringe filter. Alternately, cell cloning was performed after a single cell obtained by micromanipulation with the aid of a hand-held microcapillary tube was deposited into a microwell that had been treated as described above.
Cells were plated in agar and in methylcellulose diluted with RPMI.' The agar system consisted of an underlay of 0.5% Noble agar in RPMI containing 10% HS and an overlay of 0.3% agar in RPMI, 20% HS, GM-CSF, and MB-02 cells ranging from 5 x 102 to 1 X 10S/35-mm Petri dish. Methylcellulose plates were prepared using a final 0.9% methylcel (Dow, Midland, MI) in 1X RPMI, 20% human serum, and GM-CSF. Colonies were transferred by the use of a Pasteur pipette into round-or flat-bottom microwells containing complete medium, GM-CSF, and 20% conditioned medium.
Cells (lPiO.1 mL) were incubated with 0.4 mL of a stock suspension (0.5 mg/lO mL) of Zymosan A (Sigma) for 1 hour at 37°C. After a wash with 5 mL of 105/0.1 mL warm nutrient medium, the pellet was resuspended in 0.5 mL of complete medium and deposited onto three slides (0.15 mL/slide) using a cytocentrifuge. Cells containing Zymosan particles were visualized under a light microscope. PB mononuclear cells served as a positive control.
Total RNA was isolated from cells grown in GM-CSF as well as from cells exposed to Epo for 2,5, and 9 days. For each sample, 1 to 2 x lo' cells were pelleted, washed in 1X PBS, and snap-frozen in liquid nitrogen. RNA was isolated from the frozen pellets in the presence of ribonucleoside-vanadyl complexes (VRC)."'." After phenol extraction and ethanol precipitation, RNA pellets were rehydrated in 200 pL of water treated with diethyl pyrocarbonate (DEPC). To remove residual VRC, 10 pL of 0.5 mol/L EDTA was added and the samples were incubated at 25°C for 20 minutes. After phenol extraction, the RNA was reprecipitated and the final pellet resuspended in 100 pL of TE (10 mmol/L Tris, pH 7. EDTA). The RNA concentration was determined by spectrophotometry at 260 nm and integrity was confirmed by agarose gel electrophoresis.
Probes for S1 analysis consisted of cloned genomic fragments containing exon 2 from the E, 7 , and p genes." A common BumHI site is found 209 bp from the 5' end of this exon in each of the three genes (see Fig 7) . The sequence of this 209 bp region differs by 13% to 23% in the three genes. Thus, each end-labeled probe generates a 209-bp protected fragment that is specific for its own messenger RNA (mRNA) under the hybridization conditions described below. Probe fragments were excised from the plasmid clones by digestion with BamHI (E, 670 bp; p, 1.9 kb) or with EcoRI and BamHI (7, 1.7 kb). After treatment with calf intestinal alkaline phosphatase, fragments were isolated from low melting point agarose. The concentration of fragments was determined by OD, and reconfirmed by gel electrophoresis. Probes were labeled by T4 polynucleotide kinase in the presence of [y3'P]ATP to a specific activity of 2 to 5 x IO6 cpm/kg. Quantitative S1 analysis was performed using total RNA concentrations of 10 kg for E, 10 ng for y, or 100 ng for p. These concentrations of RNA were chosen because preliminary experiments proved that they assured conditions of probe excess. Aliquots of RNA were mixed with 30,000 to 50,000 cpm of probe (10 to 20 ng) and the mixtures were evaporated to dryness. Pellets were resuspended in 8 )LL of formamide and 2 p,L of 5X S1 buffer (2 mol/L NaCI, 200 mmol/LPIPES, pH 6.4,5 mmol/L EDTA) was added. Hybridization was performed at 52°C overnight. Samples were then digested with 300 U of S1 nuclease at 42°C for 90 minutes, ethanol precipitated in the presence of 10 kg of tRNA carrier, and loaded quantitatively onto 6% sequencing gels. After autoradiography of the dried gel, quantitative analysis was performed by scanning the gel on a Betascope Model 603 (Betagen, Waltham, MA). All experiments were performed two to three times with reproducible results.
RESULTS
Primary cultures of leukemic cells.
When thawed leukemic blasts were cultured in medium alone or in medium supplemented with Epo, moderate growth persisted for 3 weeks and then declined (Fig 1) . After an initial lag period, IL-3 or GM-CSF supported growth for two proliferative cycles, after which the cells gradually lost the capacity to respond to IL-3. These cultures consisted of eosinophils, basophils, and macrophage-like cells at termination (day 34) and could not be rescued by the addition of GM-CSF (data not shown). Only GM-CSF permitted sustained proliferation and gave rise to the MB-02 cell line. The growth response of cultures containing GM-CSF in combination with Epo and/or IL-3 were equivalent to GM-CSF alone and priority was given to the GM-CSF culture. TGF-P was capable of abrogating the residual growth of the control cultures as well as causing a delay in the GM-CSF response (Fig 1) . Recovery of the inhibited GM-CSF culture was due to the response of cells resembling early granulocytes that evolved into macrophage-like cells when the culture terminated on day 34.
The earliest indication that GM-CSF was required for cell growth occured when cells at day 36 were deprived of GM-CSF and replaced by nutrient medium alone or supplemented with IL-3 (data not shown). When the cultures began to fail 2 days later, the cells were rescued by the addition of GM-CSF (data not shown). The strict depen- Total days in culture Primary cultures were split to lower cell density (arrow) and replenished with the appropriate factor-containing medium.
dence on GM-CSF and pattern of growth after 4 months and more than 1 year in continuous culture are shown in Fig  2. When the cells were deprived of GM-CSF, rapid culture death occurred in nutrient medium alone or in IL-3-supplemented medium (Fig 2A) . Growth of the cells in the absence of serum required only GM-CSF (Fig 2B) , but these cultures could not be maintained for more than 2 weeks even when IL-3 was used in combination with GM-CSF (data not shown). Viable, proliferating cells were obtained when the Ex-Cell medium containing GM-CSF was supplemented with 1% serum. Additional testing in the presence and absence of serum showed that neither IL-2, Total days in culture 
Epo (O), or medium only (W).
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Characte&ics of the MB-02 cell line. The GM-CSFdependent cells retained the characteristic cytoplasmic blebbing described for the PB leukemic blasts and exhibited morphology of a primitive, undifferentiated cell after 10 months in culture (Fig 3A) . This morphology, with an occasional cell with heavy blue granules, has been consistent after a total culture time of 18 months. The cultured cells were reactive for acid phosphatase and periodic acid-Schiff and were negative for myeloperoxidase, chloroacetate esterase, and a-napthol acetate esterase. The cells were not functional phagocytes, as determined by their inability to engulf Zymosan particles. The cultures tested negative for mycoplasma by The American Type Culture Collection and were negative for Epstein-Barr nuclear antigen.
The karyotypes of cultured cells analyzed as early as 5 days into culture, after 5 months, and at least once a year thereafter were similar to that described for the uncultured BM cells and suggest the evolution of the MB-02 cell line from this leukemic clone. The karyotype of a cell after an accumulative culture time of over 18 months is shown in Fig 4. The population was summarized as follows: the modal chromosome (CH) number was 45 (n = 20) with a range between 43 and 50. Heterogeneity in the form of aneuploidy and marker CHs was significant. The most consistent aneuploidy was the loss of one CH 4 and both CHs 14. The number of marker CHs varied between 2 and 6. The most common of these were a ring CH (Fig 4, mar 1 ) present in 50% of the cells and possibly derived from CH 1 [r(l) (p36q21)I and a marker CH (Fig 4,  mar 2 ) possibly derived from the short arm of CH 11 and the long arm of CH 14 [der (14)t(ll;l4)(pll.2pl1.2)].
The surface phenotype of cells maintained in GM-CSF was determined by indirect immunofluorescence (Table 1 , column A). The cells expressed panmyeloid markers (CD13 and CD33), the stem cell antigen (CD34), GP IV (CD36), CD38, CD45, and complement receptors CDllb and CD35. The cells did not express antigens associated with T lymphocytes (CD2, CD3, and CD7), monocytes (CD14 and CD15), Fc receptors (CD16), or B lymphocytes (CD19, CD20, and CD21). The transferrin receptor (CD71), HLA-DR, and erythroid-associated glycophorin A (GPA) were detected at low intensity on some of the cells. The megakaryocyte markers (CD41, CD42, and CD61) were not detected. Results of at least three separate analyses spanning 3 years remained unchanged.
GP IIb/IIIa (CD41) and GP Ib (CD42) had been identifying markers of the leukemic blasts, but were lost as early as 1 month after culture initiation. The megakaryocyte markers GP IIb/IIIa and IIIa were re-expressed after 24 hours of exposure to TPA and restored to the frequency observed on the fresh PB blasts by 48 hours (Table 1, maturation of the cells, as suggested by the decrease in CD33, CD34, CD38, complement receptors, and HLA-DR. These markers are not present on maturing megakaryocytes. The erythroid-associated GPA was decreased and the transferrin receptor CD71 was lost. There was no effect on the expression of CD45. Lymphocyte or monocyte antigens were not induced even though over half of the cells became plastic-adherent and acquired macrophage-like morphology. These TPA-induced morphologic changes have been observed in Epstein-Barr virus (EBV)-transformed cells exposed to TPA in our laboratory and do not necessarily reflect monocyte differentiation. Although TPA did not induce multinucleated cells, the surface phenotype of the MB-02 cell line was consistent for a progenitor with megakaryocyte potential.
In an attempt to induce differentiation of the MB-02 cells, cells in complete medium containing or deprived of GM-CSF were supplemented with Epo (Fig 5) . In the absence of GM-CSF, Epo caused a limited proliferative response followed by growth arrest and culture death by day 18. However, when Epo was added to cells cultured in excess GM-CSF, growth was consistently superior to GM-CSF alone. Removal of the GM-CSF at day 25 resulted in a culture decline after 10 days. Morphologic examination of cultures during both Epo-induced declines showed a striking change in the morphology. Cells resembling primitive erythroblasts apptared as early as 3 days in the Epo-only cultures and progressed through well-defined morphologic stages of erythropoiesis. The rapid accumulation of mature erythroid cells occurred during the growth arrest until the predominant cells at culture death were late erythroblasts and normoblasts (Fig 3B and C) . Concomitant with the morphologic maturation was the appearance of Hb as detected by benzidine staining ( Table 2 ). The percentage of cells containing Hb remained fewer than 5% in the uninduced GM-CSF cultures. The accumulation of hemoglobinized cells was a gradual event during the 10 days after Epo induction and was independent of GM-CSF. An absolute and relative increase in benzidine-positive cells was noted for both Epo-containing cultures. After day 10, a rapid accumulation of hemoglobinized cells occurred in the Epo culture until over 90% of the cells were erythroid at culture termination. Epo in combination with GM-CSF maintained a plateau of approximately 30% hemoglobinized maturing cells and a population of cells morphologically identical to the uninduced cultures. When these cultures were deprived of GM-CSF at day 25 and supplemented with Epo only, a rapid progression through erythroid maturation occurred within 9 days ( Table 2 ). The proliferating, differentiating culture was maintained for over 3 months and appeared to be stable. Removal of GM-CSF at any time, as described above, committed the culture to terminal erythroid maturation. The Hb species detected by benzidine staining were identified by MoAbs. Globin chain distribution in cultures 8 days post-Epo that contained 40% benzidine-positive cells was visualized by immunofluorescence staining. Approximately 42% of the cells were positive for the y-chains of Hb F (Fig 6A through C) and 45% contained P-chains of Hb A Induction of differentiation by Epo.
For personal use only. on October 24, 2017. by guest www.bloodjournal.org From (Fig 6D through F) . y-Globin was distributed throughout the population of cells with uneven staining intensity, whereas @-globin appeared to be associated predominantly with small, dense, clustered cells known to be late erythroid cells by phase microscopsy (Fig 6D) . The intense staining of erythroid "nests" did not obscure adjoining nonreactive cells (Fig 6C and F) . 
GM-CSF (0). Epo alone (O), or a combination of GM-CSF and Epo (A),
of which pae of the culture was depleted (*) of GM-CSF at day 25 and continued in Epo only (A). three probes cannot be compared due to the requirement for differing amounts of total RNA and autoradiogram exposure times for each message. MB-02 cells grown in GM-CSF showed high levels of y transcripts (A and B) that accounted for 95% of globin mRNA and low levels of E in sample B. Longer exposure times showed E transcripts in sample A (not shown). Even though P message at day 0 is not readily visible on the autoradiogram, quantitation of the radiolabeled bands showed very low P expression (Fig 8 and Table 3 ). After Epo, E message was reduced until it was barely detectable after 9 days. P message was increased 20-fold by day 5 (11.5% of total globin) and was then reduced to levels corresponding to day 2 induction. y transcripts were increased threefold and then returned to uninduced levels. Expression of surface markers associated with a primitive phenotype was modulated during erythropoiesis (Table 1 , column C). As described for TPA differentiation above, the hematopoietic progenitor markers CD34 and CD38 were decreased, as were the complement receptors and HLA-DR. A striking enhancement of erythroid GPA and the transferrin receptor was noted. Expression of CD36 and CD45 persisted after Epo induction. Monocyte, lymphocyte, platelet, or late myeloid markers were not induced.
No differences in biologic properties or growth characteristics were found between cells in continuous culture for more than 1 year and cells grown after being cryopreserved for various intervals. The accumulative culture time of MB-02 cells currently being analyzed is over 550 days and involves at least three periods of cryopreservation.
Cultures 18 days after Epo induction were examined by electron microscopsy (Fig 9) . Undifferentiated cells were characterized by a primitive nucleus with fine chromatin and cytoplasm containing numerous mitochondria and ribosomes. The endoplasmic reticulum was not well-developed. The compact nuclei with clumped chromatin of the small cells has been described as distinct morphology associated with erythroblasts and norm blast^.'^ In the more mature erythroid cells, there
Ultrastructure of Epo-induced cells.
was a decrease in the mitochondria and ribosomes, while an increase in the electron density of the cytoplasm corresponded to an increased Hb content.
Single cells obtained by micromanipulation or by limiting dilution were not capable of growing in flat-or round-bottom microwells containing irradiated feeder layers of fibroblasts or mononuclear cells overlayed with nutrient and conditioned medium. Fewer than 80 cells/flat-bottom microwell containing a feeder of irradiated mononuclear cells were not successfully expanded.
Colonies were successfully obtained in both methyl-cellulose and agar systems supplemented with GM-CSF and a seed density of 0.5 to 1.0 x lo4 cellsi35-mm plate. Colonies in methylcellulose were spread and the retrieval of a single colony was not assured. The agar system provided well-isolated colonies by day 11 for colonal transfer to microwells pretreated as described or containing feeder layers. Growth of the transferred colonies did not occur even in the presence of conditioned medium. This finding was in agreement with the failure to expand low-density ( < 80 cells) cultures in the limiting dilution procedure.
Morphologic examination of the methyl-cellulose and agar colonies was performed after single colonies were deposited onto glass slides by a cytocentrifuge and stained with Wright-Giemsa or benzidine. The cloned cells retained the morphology and negative benzidine reactivity of the liquid stock cultures.
Inhibition by TGF-p. TGF-P2 (porcine) caused a delay and TGF-P1 (porcine) abrogated the growth responses to excess concentrations of GM-CSF and Epo (Fig 10) . The effect of human TGF-P1 was identical to porcine TGF-P1 and is not shown. GM-CSF-dependent growth of cells exposed to TGF-P2 appeared to be delayed with no obvious adverse effects (Fig 10A) . Decreased viability of the TGF-P1 cultures after 1 week ruled out a potential recovery of the growth-inhibited cells. Even though the Epo-induced cultures in Fig 10B were eventually terminal, TGF-P1 caused a rapid deterioration within 4 days when decreased viabilities were noted,
The effect of TGF-P on maturation was evaluated by analyzing the absolute and relative numbers of erythroid cells present 7 days after Epo induction. The TGF-P1-inhibited cultures showed a rapid increase in the percentage of benzidine-positive cells when compared with the control and TGF-P2 cultures. However, all cultures were found to contain the same absolute number of benzidinepositive cells, which ranged from 0.2 to 0.27 x 106/mL. Independent of growth inhibition, the primary Epo response of erythroid differentiation occurred.
Cloning by limiting dilution.
Colony formation and clonal expansion.
DISCUSSION
We have established a GM-CSF-dependent cell line from the PB of a patient with a myeloproliferative disorder that evolved into an acute megakaryoblastic leukemia. In an attempt to induce maturation of the platelet precursors, short-term cultures supplemented with recombinant growth factors were initiated. Preliminary growth of the leukemic blasts was equally rapid in response to GM-CSF and to IL-3, which was not unexpected because primitive cells and cell lines have receptors for these growth factor^.'^*'^ Morphologic maturation of the predominant GM-CSF-responsive cell was not observed, whereas terminal differentiation of precursors of eosinophils and macrophage-like cells was induced by IL-3.
The sensitivity of all primary cultures to growth inhibition by TGF-P reflected the primitiveness of the leukemic blasts. The effectiveness of TGF-P to inhibit growth depends on the stage of differentiation, with primitive cells being the most sensitive.I6 The emergence of immature granulocytes from cultures in which the primitive cells had been inhibited by TGF-P may have been due to the differentiation of committed granulocyte precursors that were no longer under the negative control of TGF-P. In fact, TGF-P may have even supported growth of these precursors. Jacobson et a1 recently reported that TGF-P can enhance growth of murine neutrophil colonies in response to GM-CSF."
The probability that the MB-02 cell line was derived from the leukcmic blasts is supported by the morphology, histochemistry. and karyotype of the cultured cells. Even though the attempts to clone the cell linc were not successful, the finding that all of the cultured cells were of an abnormal karyotype makes it unlikely that the cell linc contains both normal and leukcmic cells. Although the cell population Days of €PO induction contains considerable cytogenetic heterogeneity, the described biologic properties, including the karyotype, have remained stable. The karyotype does not suggest the mechanism by which GM-CSF has maintaincd the MB-02 cells in a self-renewal state. It is of interest to note that the capacity for terminal differentiation was not affected by the described aneuploidy nor by the malignant origin of the cells. Unlike most immortalized cell lines that are locked into a restricted phenotype, the MB-02 cell line responded to inducers and suppressors of growth and diffcrcntiation. Cell lines that arc factor-dependent often retain biologic properties and behavior of the in vivo counterpart." Standardization of the microenvironment was strictly monitored because lineage commitment of thc stock cultures was always at risk. Cryo-presentation of the earliest passages of the cell line in DMSO inadvertently induced erythropoiesis, as determined by morphology and bcnzidine staining. All ampulcs of cells stored in DMSO wcrc discarded and subscqucnt freezer stocks contained 10% glycerol instead of DMSO.
The surface phenotype became more primitive during the primary culturc with the loss of the platelet markers G P Ib and G P IIb/IIIa. However, TPA induced the rapid expression of G P IIb/IIIa and thc diminuition or loss of constitutive markers of early myeloid and crythroid lin- The absolute amount of radioactivity was determined after dried gels were scanned with a Betascope for 13 to 18 hours. The percentage of each globin species in the total globin population is in parentheses.
Abbreviation: cpm, protected counts per minute per microgram RNA x 10 ' . cages. Modulation of thcsc markers implied the onsct of diffcrcntiation and classified thc ccll linc as primitivc with mcgakaryocytc potential. The prcsencc of glycophorin, howcvcr, was not consistcnt with a mcgakaryocytc-rcstrictcd ccll. Thc primitivcncss of thc MB-02 cclls may havc extcndcd back to thc bipotcntial progcnitor of mcgakaryocytcs and crythrocytcs.
Thc crythroid potential was rcalizcd with thc introduction of a singlc inducer, Epo, which initiated crythropoicsis with the onsct of prolifcration, lincagc commitmcnt, and maturation. Analysis of globin protein by immunofluorcsccncc showcd thc prcscncc of y-chains, but no B-or e-chains in uninduccd cclls that wcrc benzidine ncgativc. These rcsults arc consistent with globin synthesis data published in a prcliminary rcport.5 Howcvcr, in thc same rcport, radioligand assays of Hb content suggcstcd that significant amounts of Hb A wcrc prcscnt in MB-02 cclls bcforc Epo administration. This finding is not corroboratcd by the immunofluoresccncc data nor by RNA transcript analysis.
Quantitative analysis of P-like globin messagcs in MB-02 cclls grown in GM-CSF showcd low lcvcls of e mRNA. It is possible that translation, if it occurred, resulted in levels of protein that were below the limits of detection by immunofluorescence. Although embryonic globin mRNA is not detected in normal human adult BM, several cell lines with erythroid potential have been shown to produce significant amounts of this message." MB-02 cell line expression of this embryonic gene may reflect the malignant origin of the cells or may be due to removal of the progenitor cells from the physiologic BM microenvironment. After Epo, embryonic E-and l;-chains were not detected by immunofluorescence, but comparable numbers of cells contained p-and/or y-globin chains. Whether p-and y-globin proteins were present in the same cell or in different cell populations is not clear from these experiments. Simultaneous immunofluorescent analysis by anti-y and anti+ MoAbs labeled with different fluorochromes will shed further light on this question. Transcription of the E gene was suppressed, which occurs during developmental erythropoiesis. The fetal to adult gene switch, however, did not occur because a reduction in y message was not concordant with the reported increment in p message. In fact, the kinetic responses of both globin genes to Epo were the same, but y represented 89.5% and p 11.5% of total globin mRNA. These results contrast with the protein synthesis studies of Perrine et als and the immunofluorescence data presented here that showed that p and y protein chains were present at similar levels after Epo induction. Further studies will be necessary to determine whether message stability, translational efficiency, and/or transcriptional activity of each gene contribute to this disparity.
The developing erythrocytes were derived from the GM-CSF-dependent population. When GM-CSF was not available to maintain the primitive cells, the Epo-induced cultures had a finite life-span. However, proliferating cultures containing both GM-CSF and Epo were maintained for more than 3 months. The self-renewing cells provided a constant cell pool that was available to enter the Epoinduced erythroid compartment.
The GM-CSF and Epo growth responses were abrogated by TGF-P. The inhibition of the growth response of Epo did not interfere with the ability of the first wave of cells to move through erythropoiesis. This result would suggest that a subpopulation of cells was primed for an immediate entry into a nonproliferating, maturing erythroid pool. When the proliferating pool was inhibited by TGF-p, the culture rapidly deteriorated.
The MB-02 cell line is a unique growth factor-dependent culture system consisting of putative bipotential progenitors of platelets and erythrocytes. This cell line will be of importance not only in the molecular biology of erythropoiesis from the standpoint of early commitment and differentiation, but also in the role of hematopoietic progenitors as reservoirs for viruses such as parvovirus.
